SWOT Analysis for Torrent Pharmaceuticals Ltd. - Weakness

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

Stocks with Consistent Share Price Growth (subscription)

Expensive Performers (DVM)

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

PE higher than Industry PE

PEG greater than Industry PEG

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Broker price or reco upgrades in last month

Companies with high market cap, lower public shareholding

High Piotroski Score - Companies with strong financials

Expensive Performers (DVM)

Decline in Net Profit with falling Profit Margin (QoQ)